NCT04553393 2020-12-04
Decitabine-primed Tandem CD19/CD20 CAR T Cells Plus Epigenetic Agents in Aggressive r/r B-NHL With Huge Tumor Burden
Chinese PLA General Hospital
Phase 1/2 Unknown
Clinical Trials
1 trialsPhase 1/2 × Unknown × Refractory or Relapsed Aggressive r/r B-NHL With Huge Tumor Burden × Clear all